The recent advancements in messenger ribonucleic acid (mRNA) vaccine development have vastly enhanced their use as alternatives to conventional vaccines in the prevention of various infectious diseases and treatment of several types of cancers. This is mainly due to their remarkable ability to stimulate specific immune responses with minimal clinical side effects. This review gives a detailed overview of mRNA vaccines currently in use or at various stages of development, the recent advancements in mRNA vaccine development, and the challenges encountered in their development. Future perspectives on this technology are also discussed.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1088/1748-605X/aceceb | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!